Sygnature Discovery North America
Research Services • 
Montreal, Quebec, Canada • 201-500 Employees
Company overview
| Headquarters | 2350 Rue Cohen, Suite 201, Montreal, Quebec H4R 2N6, CA |
| Phone number | +12012350 |
| Websites | |
| NAICS | 5417 |
| SIC | 873 |
| Keywords | Chemical Synthesis, CRO, Biology, Drug Discovery, Cell Biology, Chemistry, Pain, Biochemistry, Dmpk, Neuroscience, Computational Chemistry, Virtual Screening, In Vivo, Lead Optimization, Infectious Diseases, Small Molecule, Inflammation, Adme, Medicinal Chemistry, Pharmacology, Assay Development, Structural Biology, Target Identification, Metabolic Disease, Protein Production, Hit To Lead, Compound Screening, Process Chemistry, Lead Optimisation, Crystallography, Hit Finding, Oncolocy |
| Founded | 2004 |
| Employees | 201-500 |
| Socials |
Key Contacts at Sygnature Discovery North America
Claudio Sturino
Senior Director, Head Of Chemistry
James Féthiè
Senior Director At Sygnature Discovery
Hunter Shaw
Associate Director Business Development
Harun Rashid
Director
Andre Giroux
Senior Director, Human Resources And Operations
René Coulombe
Senior Director Structural Biology
John Mancuso
Director Of Chemistry And Head Of Peptide Synthesis Platform
Olivier Mohamad Soueidan
Associate Director
Jason Dupuis
Director Of Business Development
Julie Dassylva
Senior Director Human Resources
Sygnature Discovery North America Email Formats
Sygnature Discovery North America uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@nuchemsciences.com), used 95.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@nuchemsciences.com | 95.6% |
{first initial}.{last name} | j.doe@nuchemsciences.com | 4.4% |
About Sygnature Discovery North America
Sygnature Discovery, headquartered in Nottingham (UK), is a world-leading contract research organization for drug discovery. Based in the UK (Nottingham, Alderley Park, Macclesfield, Glasgow) and Canada (Montreal, Laval, Quebec) and with a staff of over 1,000, including over 900 scientists, Sygnature Discovery partners with the global pharmaceutical industry, biotechs and NfP organizations wishing to outsource part of their R&D work. Since 2004, Sygnature Discovery has delivered more than 56 new preclinical compounds, 29 clinical compounds and 1 registered, thanks to the talents of its world-class scientists, who are named on more than 500 patents. The services offered to our customers, whether integrated or à la carte, range from protein science to in vivo pharmacology via chemistry (computational, medicinal, synthetic or process), biology and DMPK to cover numerous therapeutic areas such as oncology, inflammation and immunology, neuroscience, metabolic diseases, infectious diseases, fibrotic diseases and more. To find out more, please visit www.sygnaturediscovery.com.
Sygnature Discovery North America revenue & valuation
| Annual revenue | $5,600,000 |
| Revenue per employee | $26,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues | $18,000,000 |
| Total funding | $37,600,000 |
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
Sygnature Discovery North America has 70 employees across 8 departments.
Departments
Number of employees
Funding Data
Explore Sygnature Discovery North America's funding history, including investment rounds, total capital raised, and key backers.
Sygnature Discovery North America Tech Stack
Discover the technologies and tools that power Sygnature Discovery North America's digital infrastructure, from frameworks to analytics platforms.
Video players
Security
Security
Video players
JavaScript libraries
JavaScript libraries
Maps
JavaScript libraries
JavaScript libraries
CDN
JavaScript libraries
Webmail
Qatar
France
Frequently asked questions
4.8
40,000 users
